AKT1 and hepatocellular carcinoma: Previous studies in human breast cancer cells [19] using eEF1A2 overexpression experiments and siRNA, and HCC cells [15] using eEF1A2 siRNA, have shown that eEF1A2 is a key activator of the prosurvival Akt.